Bausch Health Companies Inc

BHC:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:43 PM EST
27.25quote price arrow up+0.88 (+3.34%)
Volume
2,589,219
52 week range
11.15 - 30.38

...

Loading . . .

KEY STATS

  • Open26.52
  • Day High27.81
  • Day Low26.52
  • Prev Close26.37
  • 52 Week High30.38
  • 52 Week High Date01/21/20
  • 52 Week Low11.15
  • 52 Week Low Date03/18/20
  • Market Cap9,677.84M
  • Shares Out355.15M
  • 10 Day Average Volume4.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • 1 Year % Change-9.19

RATIOS/PROFITABILITY

  • EPS (TTM)-5.45
  • P/E (TTM)-5.00
  • Fwd P/E (NTM)6.52
  • EBITDA (MRQ)3,144.00M
  • ROE (MRQ)-125.32%
  • Revenue (MRQ)8,038.00M
  • Gross Margin (MRQ)72.14%
  • Net Margin (MRQ)-23.94%
  • Debt To Equity (MRQ)4,147.02%

EVENTS

  • Earnings Date02/17/2021
  • Ex Div Date05/18/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

Latest BHC News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other...
Joseph Papa
Chairman
Paul Herendeen
Chief Financial Officer
Christina Ackermann
Executive Vice President
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada